May-Thurner Syndrome
14
3
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Vascular Lab Resource (VLR) Biorepository
Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI
Prevalence of May-Thurner Syndrome in 1st-degree Relatives of Symptomatic Patients
The Use and Reproducibility of Duplex Ultrasound to Provide Indices of Left Common Iliac Vein Diameter
Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System
The Efficacy and Safety of Interventions on the Pelvic Veins in Pelvic Venous Disorders
Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
Color Doppler U/S vs MSCT Venography in May-Thurner Syndrome
Balloon Test for Iliac Vein Compression
Treadmill Pilot Study (Invasive Pressure Measurements in PTS)
Vascular Ultrasound Versus Intravascular Ultrasound for Diagnosing Iliac Vein Obstruction
Iliac Vein Stenting in Advanced Chronic Venous Insufficiency
Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation